Acamprosate Protects Rat Brain Against Middle-Cerebral-Artery-Occlusion-Induced Ischemic Injuries Through Anti-Oxidative Activities

Qinghua Lv,Lingchen Xu,Haibin Dai
2016-01-01
Abstract:It is has been reported that acamprosate significantly reduces neurological deficits following transient hemispheric ischemia, which may be related to its antiglutamatergic effect. However, it is unclear whether acamprosate may provide anti-oxidative neuroprotection in cerebral ischemic condition. To investigate the anti-oxidative neuroprotective effects of acamprosate during focal cerebral ischemia, rats were treated with acamprosate through sublingual vein injection 30 min after the onset of MCAO-induced cerebral ischemia. The behavioral tests were performed to evaluate neurological performance. 2,3,5-triphenyltetrazolium chloride (TTC) staining was used to evaluate the infarct area of brain tissue. Spectrophotometric assay was used to determine the activities of superoxide dismutase (SOD) and glutathione-peroxidase (GSH-Px), and contents of malondialdehyde (MDA) and adenosine triphosphate (ATP). Furthermore, the respiratory control ratio (RCR = State 3/State 4) was calculated to determine the brain mitochondria activities. Acamprosate at doses of 30 and 100 mg/kg, but not 10 mg/kg, exhibited significant neuroprotective effects against focal cerebral ischemic injury by markedly attenuating MCAO-induced neurological deficit, and reducing the infarct area. Meanwhile, acamprosate significantly improved mitochondrial energy metabolism, and countered the reduction of SOD and GSH-Px activities and elevation of MDA level induced by cerebral ischemia. Acamprosate might provide neuroprotection against the cerebral ischemia-induced injury through antioxidative actions in the brain.
What problem does this paper attempt to address?